GlaxoSmithKline PLC (NYSE:GSK)
| 47.16 Delayed Data As of Jan 16 |  -0.45 / -0.95%Today’s Change | 38.16 Today|||52-Week Range 47.79 | +0.36% Year-to-Date |
Latest GSK News | Press Releases
| 5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals Jan 16 / MotleyFool.com - Paid Partner Content | Is Pfizer's Stock a Buy? Jan 14 / MotleyFool.com - Paid Partner Content |
| Here's Why Clovis Oncology Rose as Much as 25.6% Today Jan 15 / MotleyFool.com - Paid Partner Content | Here's Why SpringWorks Therapeutics Climbed 69% in December Jan 12 / MotleyFool.com - Paid Partner Content |
| FDA Gives Clovis Oncology's Rubraca a Priority Review Jan 15 / MotleyFool.com - Paid Partner Content | 3 Dividend Stocks Yielding More Than 4% That Are Safe Buys in 2020 Jan 11 / MotleyFool.com - Paid Partner Content |
| Will Theravance Biopharma Finally Break Out in 2020? Jan 14 / MotleyFool.com - Paid Partner Content | Axsome Therapeutics: Buy at the High? Jan 07 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.61 |
| Today’s open | 47.06 |
| Day’s range | 46.93 - 47.35 |
| Volume | 3,086,250 |
| Average volume (3 months) | 2,509,236 |
| Market cap | $116.8B |
Data as of 6:30pm ET, 01/16/2020
Growth & Valuation
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | +2.38% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 19.7 |
| Price/Sales | 2.31 |
| Price/Book | 20.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -1.08 | -1.73% |
| SNYSanofi | -0.06 | -0.12% |
| ABBVAbbVie | 0.00 | 0.00% |
| AZNAstraZeneca | -0.29 | -0.57% |
Data as of 6:30pm ET, 01/16/2020
Financials
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brentford, Greater London |
Forecasts
